Temozolomide resistance in glioblastoma multiforme-Reference-Cited by-同舟云学术

Temozolomide resistance in glioblastoma multiforme

Published:2016-09 Issue:3 Volume:3 Page:198-210
ISSN:2352-3042
Container-title:Genes & Diseases
language:en
Short-container-title:Genes & Diseases

Author:

Lee Sang Y.

Funder

Gittlen Foundation

Publisher

Elsevier BV

Subject

Cell Biology,Genetics (clinical),Molecular Biology,Biochemistry

Reference54 articles.

1. The medicinal chemistry of imidazotetrazine prodrugs;Moody;Pharmaceuticals (Basel),2014

2. Pharmacokinetics of 3-methyl-(triazen-1-yl)imidazole-4-carboximide following administration of temozolomide to patients with advanced cancer;Reid;Clin Cancer Res,1997

3. Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma;Middleton;J Clin Oncol,2000

4. Temozolomide for the treatment of metastatic melanoma: a systematic review;Quirt;Oncologist,2007

5. Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group;Yung;J Clin Oncol,1999

Cited by 708 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptomic analysis identifies the neuropeptide cortistatin (CORT) as an inhibitor of temozolomide (TMZ) resistance by suppressing the NF-κB-MGMT signaling axis in human glioma;Genes & Diseases;2024-05

2. Specific transport of temozolomide does not override DNA repair-mediated chemoresistance;European Journal of Pharmaceutical Sciences;2024-04

3. The impact of calcium-binding protein S100P on temozolomide sensitivity in glioblastoma cells;Gene Reports;2024-03

4. Multitarget Potential Drug Candidates for High-Grade Gliomas Identified by Multiple Reaction Monitoring Coupled with In Silico Drug Repurposing;OMICS: A Journal of Integrative Biology;2024-02-06

5. Discovery of N-alkyl-N-benzyl thiazoles as novel TRPC antagonists for the treatment of glioblastoma multiforme;European Journal of Medicinal Chemistry;2024-02